Bank of New York Mellon’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Buy |
+13,662
| New | +$308K | ﹤0.01% | 3767 |
|
|
2024
Q1 | – | Sell |
-499
| Closed | -$7.27K | – | 4322 |
|
|
2023
Q4 | $7.27K | Hold |
499
| – | – | ﹤0.01% | 4274 |
|
|
2023
Q3 | $11.9K | Hold |
499
| – | – | ﹤0.01% | 4275 |
|
|
2023
Q2 | $6.61K | Hold |
499
| – | – | ﹤0.01% | 4349 |
|
|
2023
Q1 | $39K | Hold |
499
| – | – | ﹤0.01% | 4233 |
|
|
2022
Q4 | $41.5K | Hold |
499
| – | – | ﹤0.01% | 4262 |
|
|
2022
Q3 | $46K | Sell |
499
-25
| -5% | -$2.31K | ﹤0.01% | 4337 |
|
|
2022
Q2 | $79K | Buy |
524
+25
| +5% | +$3.77K | ﹤0.01% | 4276 |
|
|
2022
Q1 | $121K | Sell |
499
-3
| -0.6% | -$727 | ﹤0.01% | 4367 |
|
|
2021
Q4 | $152K | Hold |
502
| – | – | ﹤0.01% | 4340 |
|
|
2021
Q3 | $208K | Buy |
502
+256
| +104% | +$106K | ﹤0.01% | 4197 |
|
|
2021
Q2 | $76K | Sell |
246
-1,300
| -84% | -$402K | ﹤0.01% | 4255 |
|
|
2021
Q1 | $318K | Sell |
1,546
-24
| -2% | -$4.94K | ﹤0.01% | 3881 |
|
|
2020
Q4 | $314K | Sell |
1,570
-94
| -6% | -$18.8K | ﹤0.01% | 3807 |
|
|
2020
Q3 | $275K | Buy |
1,664
+5
| +0.3% | +$826 | ﹤0.01% | 3749 |
|
|
2020
Q2 | $412K | Hold |
1,659
| – | – | ﹤0.01% | 3569 |
|
|
2020
Q1 | $303K | Sell |
1,659
-14
| -0.8% | -$2.56K | ﹤0.01% | 3589 |
|
|
2019
Q4 | $484K | Buy |
1,673
+142
| +9% | +$41.1K | ﹤0.01% | 3607 |
|
|
2019
Q3 | $418K | Buy |
1,531
+175
| +13% | +$47.8K | ﹤0.01% | 3636 |
|
|
2019
Q2 | $509K | Sell |
1,356
-77
| -5% | -$28.9K | ﹤0.01% | 3586 |
|
|
2019
Q1 | $384K | Hold |
1,433
| – | – | ﹤0.01% | 3646 |
|
|
2018
Q4 | $305K | Buy |
1,433
+9
| +0.6% | +$1.92K | ﹤0.01% | 3698 |
|
|
2018
Q3 | $638K | Buy |
1,424
+67
| +5% | +$30K | ﹤0.01% | 3517 |
|
|
2018
Q2 | $551K | Sell |
1,357
-1,076
| -44% | -$437K | ﹤0.01% | 3591 |
|
|
2018
Q1 | $1.33M | Buy |
2,433
+1,462
| +151% | +$797K | ﹤0.01% | 3047 |
|
|
2017
Q4 | $587K | Buy |
971
+25
| +3% | +$15.1K | ﹤0.01% | 3527 |
|
|
2017
Q3 | $436K | Buy |
946
+59
| +7% | +$27.2K | ﹤0.01% | 3634 |
|
|
2017
Q2 | $359K | Buy |
+887
| New | +$359K | ﹤0.01% | 3743 |
|